IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:IDT Australia Ltd (IDT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013550
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes in the post-discovery pharmaceutical life cycle. It manages Cytotoxic API’s, high potency API’s, anti-cancer drugs, antibiotics, anti-psychotics, beta lactams and controlled drugs. IDT provides a wide range of services, which can be customized to meet the specific requirements of its customer. The company also provides specialist clinical trial labeling, packaging and dispensing services. IDT is headquartered in Boronia, Victoria, Australia.

IDT Australia Ltd (IDT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Partnerships 12
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
Equity Offering 14
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For US$2.8 Million 15
IDT Australia Completes Private Placement Of Shares For US$0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For US$1.8 Million 17
Asset Transactions 18
I’rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 18
Acquisition 19
I’rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 19
I’rom Completes Acquisition Of 18.8% Stake In IDT Australia For US$2 Million 20
IDT Australia Ltd – Key Competitors 21
IDT Australia Ltd – Key Employees 22
IDT Australia Ltd – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Strategy And Business Planning 24
Mar 30, 2016: IDT Greatly Expands Generics Production Capacity with New Manufacturing Partner 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
IDT Australia Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IDT Australia Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For US$2.8 Million 15
IDT Australia Completes Private Placement Of Shares For US$0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For US$1.8 Million 17
I'rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 18
I’rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 19
I'rom Completes Acquisition Of 18.8% Stake In IDT Australia For US$2 Million 20
IDT Australia Ltd, Key Competitors 21
IDT Australia Ltd, Key Employees 22

★海外企業調査レポート[IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apex Healthcare Berhad (AHEALTH):企業の財務・戦略的SWOT分析
    Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Probiogen AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Probiogen AG (Probiogen) a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeut …
  • Asarco LLC:企業の戦略・SWOT・財務分析
    Asarco LLC - Strategy, SWOT and Corporate Finance Report Summary Asarco LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Grifols SA (GRF)-医療機器分野:企業M&A・提携分析
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • XL Group Ltd:戦略・SWOT・企業財務分析
    XL Group Ltd - Strategy, SWOT and Corporate Finance Report Summary XL Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The Tokyo Star Bank Ltd:企業の戦略・SWOT・財務情報
    The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TOTAL S.A.:企業のM&A・事業提携・投資動向
    TOTAL S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TOTAL S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • DSE, Inc.:企業の戦略・SWOT・財務情報
    DSE, Inc. - Strategy, SWOT and Corporate Finance Report Summary DSE, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Saudi Pharmaceutical Industries & Medical Appliances Corp (2070):製薬・医療:M&Aディール及び事業提携情報
    Summary Saudi Pharmaceutical Industries & Medical Appliances Corp (SPIMACO) develops, manufactures, and sells pharmaceutical products and medical appliances. The company offers its products in anti-infectives, cardio-vascular, diabetes, GIT, iron supplement, men health, musculoskeletal, pschychatric …
  • Aegean Marine Petroleum Network Inc (ANW):石油・ガス:M&Aディール及び事業提携情報
    Summary Aegean Marine Petroleum Network Inc (AMPL) is a provider of marine fuel logistics services. The company markets and offers refined marine fuels and lubricants to ships. Its lubricants include marine fuels, mineral, cargo trading, marine lubricants, synthetic and next generation bio degradabl …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務分析
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Borr Drilling Ltd (BDRILL):石油・ガス:M&Aディール及び事業提携情報
    Summary Borr Drilling Ltd (Borr Drilling) is a provider of drilling services for offshore oil and gas industry. The company owns and operates modern jack-up drilling rigs and deliver drilling operations in hydrocarbon basins around the globe. It has operational presence in Norway, Bermuda and the UA …
  • American Shared Hospital Services (AMS):医療機器:M&Aディール及び事業提携情報
    Summary American Shared Hospital Services (ASHS) is a healthcare company that offers medical equipment to hospitals and medical centers. The company offers financial and healthcare tech solutions. Its financing solutions comprise feasibility studies and reimbursement analysis, facilities planning an …
  • BSN medical GmbH-医療機器分野:企業M&A・提携分析
    Summary BSN medical GmbH (BSN medical) is healthcare company specialized in compression therapy, wound care and othropedics. It manufactures and markets medical products for wound care and related vascular diseases, lumphology and non-invasive orthopedic products. The company's product line includes …
  • Shangri-La Hotels (Malaysia) Berhad:戦略・SWOT・企業財務分析
    Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Hotels (Malaysia) Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Cobb Electric Membership Corporation:企業の戦略的SWOT分析
    Cobb Electric Membership Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析
    GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Aptevo Therapeutics Inc (APVO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptevo Therapeutics Inc (Aptevo), a subsidiary of Emergent Biosolutions Inc, is a biotechnology company that develops and commercializes oncology and hematology therapeutics. The company’s only marketed product Ixinity that is indicated to replace the missing clotting factor IX in adults and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆